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Associations of depression and anxiety with substance use and social health
among older adults living with HIV
Abstract
Life expectancy after HIV infection dramatically increased following the development of antiretroviral
therapies (ART) in 1996. As the population of older adults living with HIV increases, concerns have grown
about possible disparities in mental health. We evaluated mental health outcomes, specifically depressive
symptoms and anxiety, among older adults living with HIV in two large urban cities. We also examined the
relationship between mental health outcomes and substance use and social health. We recruited 154
participants from infectious disease clinics in Los Angeles, CA and New Orleans, LA to complete crosssectional surveys. We assessed prevalence of depressive symptoms (CES-D-10) and anxiety (GAD-7).
Bivariate analyses and multivariate linear regressions were run to examine the factors associated with
depressive symptoms and anxiety. We found that 44.8% of all participants were at risk for clinical
depression, 55.8% reported mild to severe levels of anxiety, and 40.0% met criteria for both. In multivariate
analyses, greater depressive symptoms and anxiety were associated with greater perceived HIV-related
stigma and smaller social networks. Depressive symptoms were additionally associated with younger
age. Substance use was not associated with depressive symptoms or anxiety. Findings suggest older
adults living with HIV may be at high risk for depression and anxiety and that the presence of these
conditions may also be linked to poorer social health indicators. This highlights the importance of
screening for and addressing depression and anxiety among older adults with HIV.
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Abstract
Life expectancy after HIV infection dramatically increased following the development of
antiretroviral therapies (ART) in 1996. As the population of older adults living with HIV
increases, concerns have grown about possible disparities in mental health. We evaluated mental
health outcomes, specifically depressive symptoms and anxiety, among older adults living with
HIV in two large urban cities. We also examined the relationship between mental health
outcomes and substance use and social health. We recruited 154 participants from infectious
disease clinics in Los Angeles, CA and New Orleans, LA to complete cross-sectional surveys.
We assessed prevalence of depressive symptoms (CES-D-10) and anxiety (GAD-7). Bivariate
analyses and multivariate linear regressions were run to examine the factors associated with
depressive symptoms and anxiety. We found that 44.8% of all participants were at risk for
clinical depression, 55.8% reported mild to severe levels of anxiety, and 40.0% met criteria for
both. In multivariate analyses, greater depressive symptoms and anxiety were associated with
greater perceived HIV-related stigma and smaller social networks. Depressive symptoms were
additionally associated with younger age. Substance use was not associated with depressive
symptoms or anxiety. Findings suggest older adults living with HIV may be at high risk for
depression and anxiety and that the presence of these conditions may also be linked to poorer
social health indicators. This highlights the importance of screening for and addressing
depression and anxiety among older adults with HIV.
*Corresponding author can be reached at: annie.nguyen@med.usc.edu
People ages 50 or older make up about 50% of all people living with HIV (PLWH) in the
United States and that number is expected to grow (CDC, 2019). As PLWH enjoy longer life
expectancies, there is a growing body of research that focuses on identifying and addressing
mental health challenges that older PLWH may face. Depression and anxiety are of particular
concern because these conditions are prevalent among PLWH at higher rates compared to the
general adult population (Grov et al., 2010; Johnson Shen et al., 2019; McGowan et al., 2018).
Depressive symptoms are prevalent in 6-15% of the general, community-dwelling older adult
population (Akincigil et al., 2011) and anxiety is estimated to affect upwards of 15% of
community-dwelling older adults (Wolitzky-Taylor et al., 2010). Depression and anxiety are
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often comorbid and both conditions can have significant impacts on health and HIV disease
management for PLWH. Depression is associated with poorer medication adherence, lower
CD4+ cell counts, and higher viral loads (Shacham et al., 2009; Tufano et al., 2015). Anxiety
symptoms are associated with HIV-related somatic symptoms and emotion dysregulation (Brandt
et al., 2017). In general, depression and anxiety are individual risk factors for suicide ideation
with comorbid depression and anxiety posing elevated risk for suicide ideation (Almeida et al.,
2012).
While depression and anxiety are not challenges that are unique to aging populations or
to PLWH, older PLWH may face factors that increase vulnerability to poor mental health
outcomes. Older PLWH are more likely than younger PLWH to have experienced compounded
stigmas due to HIV status, sexual orientation, and age (Emlet et al., 2015; Johnson Shen et al.,
2019). Older PLWH have weaker social ties and smaller social networks compared to general
older populations (Emlet, 2006; Shippy & Karpiak, 2005). Depressive disorders are frequently
comorbid with substance use disorders (Davis et al., 2008) and compared to their HIV-negative
counterparts, older PLWH are more likely to report past or current substance use. One study
found the rate of illicit substance use among urban-dwelling older PLWH to be 37% (Deren et
al., 2019). Cohort differences may be a driver of likelihood for substance use with the baby
boomer generation using alcohol and other substances at higher rates compared to previous
generations (Deren et al., 2019).
In this study, we evaluated the prevalence of depressive symptoms and anxiety in a group
of ethnically diverse older PLWH and examined the factors associated with depression and
anxiety. We drew from two catchment areas for this study- Los Angeles, California and New
Orleans, Louisiana. According to the most recently available surveillance data, the HIV
prevalence rate in Los Angeles was 501 per 100,000 population with 48% of all PLWH being
ages 50 and over (Division of HIV and STD Programs, 2018). The prevalence rate in New
Orleans was over 400 per 100,000 population. The age breakdown in New Orleans is not
reported by the Louisiana Department of Health, but 52% of all PLWH in the state of Louisiana
were ages 45 and over (State of Louisiana Department of Health, 2017). Both cities are urban
areas though some differences may exist in terms of density of HIV-related services. For
example, a search for AIDS Services Organizations (ASO) on a website managed by the U.S.
Department of Health and Human Services (www.locator.aids.gov) yielded 333 listings within
Los Angeles and 117 listings within New Orleans. Thus, it is worth noting that availability of
HIV-related services may differ between these two cities.
Methods
Cross-sectional data were collected from individuals living with HIV who were ages 50
or older. A total of 154 participants were recruited from infectious disease clinics in Los
Angeles, California (n = 80) and in New Orleans, Louisiana (n = 74). At both sites, potential
participants were approached by research assistants in the clinic waiting rooms and handed flyers
describing the study. Those who were interested in the study were screened for the inclusion
criteria, that is: 1) ages 50 or older, 2) HIV-positive, and 3) able to complete a survey in English.
Eligible participants completed the survey in a private space at the clinic either before or after
their appointments. Surveys were anonymous and gift card incentives were provided for
participation. Additional details on study procedures are published elsewhere (Nguyen et al.,
2019).
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Measures
Mental health outcomes. The CES-D-10 (Cronbach's α = .81; Kohout et al., 1993;
Zhang et al., 2012) and GAD-7 (Cronbach's α = .93; Dear et al., 2011; Löwe et al., 2008; Spitzer
et al., 2006) measures were used to assess risk for depression and anxiety, respectively. Scores
for each item on the CES-D-10 were summed for a total score. The cut-off for clinical depression
is a total score of ≥ 10. Items on the GAD-7 were summed with higher scores indicating greater
levels of anxiety. Recommended cut-offs used to classify severity of anxiety are: ≤ 5, no anxiety;
5-9, mild anxiety; 10-14, moderate anxiety; and ≥ 15, severe anxiety.
Demographics. Demographic information collected from participants included age,
gender, race/ethnicity, highest level of education completed, sexual orientation, relationship
status (partnered/married vs. not partnered/single), and living situation (live alone vs. live with
other people). We also collected self-reported data on HIV characteristics: years living with HIV,
CD4+ cell count range (> 500 indicates healthy range), and viral load detectability (undetectable
vs. detectable).
Social health and substance use. The Perceived Stigma Scale (Cronbach's α = .85;
Herek & Capitanio, 1993) was used to assess perceived HIV-related stigma. Participants
indicated their level of agreement with statements such as “People gossip about my HIV status”
and “I feel discriminated by health workers”. Items were summed and higher total scores
indicate greater perceived HIV-related stigma.
Social support was measured using the Lubben Social Network Scale (LSNS-6)
(Cronbach's α = .91; Lubben et al., 2006) which assessed support received from both kin and
non-kin sources. The total score was calculated by a sum of the six items with a total possible
range of 0-30. Higher scores indicate larger social networks.
To assess substance use, we asked whether the patient had used: 1) any illicit substance
(e.g., cocaine, crack, methamphetamines, heroin, opioids without a prescription), 2) marijuana,
or 3) alcohol within the past six months. Use of these three substances were treated as separate
dichotomous variables.
Data Analyses
Descriptive statistics were used to characterize the overall sample. Bivariate analyses
identifying associations between depression and anxiety, separately, and variables of interest
were performed using Pearson correlations for continuous variables and one-way ANOVA and ttests for categorical variables. Variables that were significant in bivariate analyses were included
as covariates in linear regressions modelled for depression and anxiety scores separately. Critical
alpha was set at 0.05.
Study Findings
Participants’ mean age was 56.7 years (SD = 5.1) with a mean of 18.1 years (SD = 8.8)
living with HIV. The majority were male (72.1%), black/African American (61.7%), single/not
partnered (72.1%), and living alone (56.5%), and had completed high school or more (74.1%).
Most people reported non-detectable viral loads (83.1%) and CD4+ ranges in the normal target
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range of greater than 500 (87.7%). Almost half of participants (43.5%) self-identified as gay,
lesbian, or bisexual. There were no significant demographic differences between participants by
recruitment site in terms of age, gender, education, years living with HIV, CD4+ range, viral
load detectability, and living arrangement. There were some differences by racial/ethnic
composition and sexual orientation, where participants in Los Angeles had a greater composition
of Hispanic participants (35.0% vs. 5.4%), fewer whites (7.5% vs. 21.6%), and more participants
who identified as heterosexual (67.1% vs. 51.4%). See Table 1.
Overall, mean CES-D-10 scores were 9.7 (SD = 6.5) with 44.8% of participants falling
into the category of being at risk for clinical depression (scores ≥ 10). Mean GAD-7 scores were
6.9 (SD = 6.4) with 14.9% meeting criteria for severe anxiety ≥ 15, 16.9% for moderate anxiety
(10-14), and 24.0% for mild anxiety (5-9). Out of all 154 participants, 38.3% did not meet
criteria for depression or any level of anxiety, 16.9% met criteria for anxiety alone, 5.8% met
criteria for depression alone, and 40.0% met criteria for both depression and anxiety.
Bivariate analyses. Scores for depressive symptoms were not significantly associated
with years living with HIV, gender, relationship status, living situation, race/ethnicity, sexual
orientation, CD4+ range, marijuana use, alcohol use, or illicit substance use. Depressive
symptoms were higher in participants who completed high school vs. those who completed some
college or more (11.4 vs. 8.2; p = 0.03). Greater depressive symptoms were associated with
younger age (p = 0.01), greater stigma (p < 0.001), and smaller social networks (p = 0.01).
Anxiety scores were not significantly associated with years living with HIV, number of
health conditions, gender, relationship status, living situation, race/ethnicity, sexual orientation,
education, CD4+ range, marijuana use, alcohol use, or illicit substance use. Increasing anxiety
scores were associated with younger age (p = 0.005), greater stigma (p < 0.001), and smaller
social networks (p = 0.03).
Linear regressions for depression and anxiety scores and stratified analyses. In a
linear regression model accounting for age, education, stigma, and social network size, more
depressive symptoms remained associated with greater stigma (p < 0.001). See Table 2. In a
linear regression model accounting for age, stigma, and social network size, higher anxiety
scores remained associated with younger age (p = 0.3) and greater stigma (p < 0.001). See
Table 3.
Discussion
Risk for depression and anxiety were present at high rates among the participants in this
study and comorbid risks for depression and anxiety were common. The results from the
multivariate analyses suggested that the most salient factors associated with greater risk for
depression and anxiety were younger age, smaller social networks, and greater HIV-related
stigma. This is consistent with findings from other studies. In a study by Emlet and colleagues
(2015), 44% of PLWH under the age of 40 had depression compared to 26% of people over age
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Table 1
Participant Demographics for All Participants and by Recruitment Site
Variable

All participants
(N = 154)

Los Angeles
(n = 80)

New Orleans
(n = 73)

56.8 (5.1)

56.7 (5.0)

56.8 (5.2)

Sex (male)

72.1%

76.2%

67.6%

Heterosexual

56.5%

67.1%

32.9%

Hispanic

20.8%

35.0%

5.4%

White

14.3%

7.5%

21.6%

Black/African American

61.7%

55.0%

68.9%

API and other

3.2%

2.5%

4.1%

<High school

26.0%

23.8%

28.4%

High school

31.2%

35.0%

27.0%

Some college or more

42.9%

41.3%

44.6%

Single/not partnered

72.1%

72.5%

71.6%

Lives alone

56.5%

55.0%

58.1%

18.1 (8.8)

18.2 (8.9)

18.0 (9.1)

CD4 count > 500

87.7%

86.3%

89.2%

Undetectable viral load

85.3%

84.8%

85.9%

Age (years), M (SD)

Race/ethnicity

Education

Years with HIV, M (SD)
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Table 2
Linear Regression Model with Depressive Symptoms (CES-D-10 scores) as the Dependent
Variable
SE
0.10

T
-1.74

p-value
0.08

Education (<HS vs. some college or more) 0.84

1.24

0.68

0.50

Education (HS vs. some college or more)

2.10

1.16

1.82

0.07

Social network score

-0.09

0.06

-1.49

0.14

Stigma score

0.34

0.09

3.57

< 0.001

Age

Variables

B
-0.18

F(5, 148) = 6.53, p < .0001, adjusted r2 = 0.15
Table 3
Linear Regression Model with Anxiety (GAD-7 scores) as the Dependent Variable.
B
-0.22

SE
0.10

T
-2.26

p-value
0.03

Social network score

-0.06

0.06

-0.99

0.32

Stigma score

0.32

0.09

3.44

0.001

Age

Variables

F(3, 147) = 8.39, p < .0001, adjusted r2 = 0.13
55. McGowen and colleagues (2018) found depression and anxiety to be prevalent among 20%
and 16%, respectively, in their study population of adults with HIV with a mean age of 48.
We found depression and anxiety to be associated with higher perceived stigma among
our participants. Some studies have found levels of perceived stigma to be lower among older
adults (Emlet et al., 2015; Emlet et al., 2013) but stigma and its impact on health outcomes is
multifaceted and complex. Older adults living with HIV may experience multiple forms of
stigma including intersectional stigma which results from marginalization based on more than
one identity such as age, sexual orientation, gender, or race (Sangaramoorthy et al., 2017; Slater
et al., 2015). Thus, older adults living with HIV may face stigma related to multiple factors in
addition to their disease status and more research is needed to disentangle the impact of
intersectional stigmas and related experiences such as discrimination and trauma.
Depression and anxiety were associated with lower social network scores in our study. A
possible explanation for this association is that smaller social networks contribute to the
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development of depression and anxiety. Greater social support for people with HIV is associated
with less distress, greater positive affect, and better medication adherence (Mavandadi et al.,
2009), so smaller networks may contribute to distress and poorer affect and medication
adherence. Conversely, the symptoms of depression and anxiety can prevent one from expanding
and maintaining one’s social network (Audet et al., 2013). For example, depression can result in
low energy and loss of interest in activities, and patients with such symptoms may engage less
frequently with friends and family. People with anxiety may experience anxiety when engaging
with their social networks, leading to avoidance of social interactions. Thus, the association
between social network size and mental health outcomes is likely to be bidirectional.
Depression and anxiety were not associated with some factors previously shown to be
associated or conventionally thought to be associated with depression and anxiety, namely HIV
progression. Less than 20% of participants had advanced HIV infection (as measured by CD4+
cell count < 200 cells/μL and detectable viral load). However, data were obtained through selfreport, and patients may not have known or reliably reported their CD4+ cell counts or viral
loads. It is also possible that laboratory markers of disease and clinical diagnoses are less reliably
related to the mental health compared to other social factors.
Finally, we note that the clinics from which participants were recruited received funding
by the Ryan White HIV/AIDS Program under the auspices of the Health Resources and Services
Administration (HRSA), which aims to provide HIV primary care, medications, and other
essential HIV-related services for low income people who are uninsured and underserved. Thus,
the participants in this study may represent individuals from lower socioeconomic strata and
shoulder the multiple burdens associated with poverty including lack of access and options for
comprehensive medical and mental health care, unmet basic day-to-day needs such as food
security, housing, and transportation, and reliable and stable employment opportunities. Stressful
life situations that arise from socioeconomic disadvantage are associated with a host of health
disparities, including disparities in mortality and mental health (Adler & Rehkoph, 2008).
Although socioeconomic data was not collected in this study, the stresses associated with low
socioeconomic status may be a contributing factor to the high rates of depression and anxiety
seen in this sample.
Implications for Health Behavior Theory
Most of the participants represented in this study were long-term survivors. Self-reported
information on viral load indicated that the majority of participants were undetectable, which
suggests high levels of adherence to antiretroviral medication. However, even within the context
of long-term survivors who are linked to medical care, mental health outcomes may still be poor.
This has implications on efforts to keep patients in care and particularly within the context of
HIV, engaged in the HIV care continuum. The HIV care continuum emphasizes the importance
of linking people with HIV to medical care and promoting adherence to antiretroviral
medications in order to improve health outcomes and reduce HIV transmission (Gardner et al.,
2011). This focus on the care continuum is a priority of the National HIV/AIDS Strategy for the
United States. Research and health promotion efforts have been targeted at increasing HIV
testing, willingness to seek medical care, and medication adherence. However, our findings
suggest that being connected to comprehensive medical care, which includes mental health
services, should be a major consideration. Unaddressed poor mental health can have a cascade
effect not just on efforts to keep individuals engaged in medical care but on individual health,
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well-being, and overall quality of life. Older PLWH who are not already connected to medical
services may have even greater difficulty accessing mental health resources. Thus, federal, state,
and local programs should aim to increase access to mental health services for PLWH by
increasing funding and availability of culturally-appropriate mental health programs. Addressing
stigma may necessarily go hand in hand with addressing the mental health needs of older PLWH.
Researchers and policymakers can draw on lessons learned from interventions that have been
successful in reducing HIV-related stigma in different settings within the United States, as well
as international settings (Pulerwitz et al., 2010) and incorporate practices into programs that
address mental health.
Study Limitations
Due to our use of cross-sectional analyses, causality may not be inferred. Depression and
anxiety were measured using CES-D-10 and GAD-7, respectively, which are screening tools that
do not necessarily suggest a clinical diagnosis for depression or anxiety. Nonetheless, these are
reliable and valid tools and the prevalence of depressive and anxiety symptoms are worrisome
and suggests participants are vulnerable to poor mental health outcomes. In this study, levels and
frequency of substance use were not measured. We assessed participants’ alcohol and drug use in
the last six months but did not capture lifetime substance use or past substance misuse diagnosis
or treatment. Participants were recruited through Ryan White funded primary care clinics and
represented an uninsured or underserved population that is already linked to care, so findings
may not apply to other study populations.
Conclusion
Depression and anxiety were present at high rates in a population of older adults with
HIV recruited from infectious disease clinics in two large urban areas. Depression and anxiety
were associated with greater perceived stigma and smaller social networks. Depression, but not
anxiety, was associated with younger age. Results suggest the importance of actively screening
for and treating mental health issues, even in patient populations that may already be linked to
care. Attention needs to be paid to the social context of older adults living with HIV to mitigate
vulnerability to poor mental health outcomes.
Discussion Questions
1. Findings from this study suggest mental health concerns may be prominent among older
people living with HIV. Given these results were found in the sample of participants who
were connected to clinical care, what are the implications for people who are not already
connected to care?
2. The HIV Care Continuum emphasizes the importance of linking people living with HIV
into care with the goal of achieving viral suppression. How might addressing mental
health care enhance the HIV Care Continuum?
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